Patent · US Active

Compounds and compositions for treating conditions associated with NLRP activity

US11447460B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Gary D. Glick · Ann Arbor, US
Shomir Ghosh · Brookline, US
William R. Roush · West Jupiter, US
Dong-Ming Shen · Edison, US

Key dates

Filing date	Apr 18, 2017
Grant date	Sep 20, 2022
Priority date	—
Expiry date	Apr 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D307/82
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.